Targeting DNA amplification is another possible way to directly target MYCN. The genome-editing tool CRISPR-Cas9 is able to cut DNA at a targeted location and lead to cancer cell death if the targeted regions contain copy number gains. The gene discussed is MYCN; the disease is cancer.